ISPOR - Analysis of Eribulin Mesylate Utilzation in Patients with Metastatic Breast Cancer (Mbc) by Line of Therapy and Associated Changes Over Time

Full Text

Analysis of Eribulin Mesylate Utilzation in Patients with Metastatic Breast Cancer (Mbc) by Line of Therapy and Associated Changes Over Time

Abstract

Authors

BA Feinberg J Drenning DF Garofalo J Montgomery

Back to Volume 18, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now